The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions

Editor's note: This story has been updated to reflect the FDA's approval Friday of Agile Therapeutics' hormonal contraceptive patch Twirla.  Biotech stocks were quiet in the week ending Feb. 14 amid some